PreCyte
Business Services · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
401 Terry Ave N, Seattle, Washington, 98...Phone Number
(206) 732-1267Website
www.precyte.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PreCyte
PreCyte offers the Indicator Cell Assay Platform (iCAP), an innovative and cost-effective blood-based assay designed for early disease detection and as a companion diagnostic in drug development. The iCAP utilizes standardized cultured cells as biosensors to enhance the detection of signals in blood or other fluids from both healthy and diseased individuals. Its unique approach leverages gene expression profiling and machine learning to quantify cellular responses, providing high sensitivity and specificity that address common diagnostic challenges. The intended clients for PreCyte's services include healthcare providers and pharmaceutical companies focused on improving disease detection and treatment development.Explore more
PreCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PreCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once PreCyte has new funding data
Click to see if PreCyte had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if PreCyte has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at PreCyte
PreCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if PreCyte is spiking on competitors!
Product Launch: Get notified when PreCyte launches new products
Earning: See what the market has to say on PreCyte recently announced quarterly report
Recommended Actions
Find VP level buyers at PreCyte
Find 2 more new buyers
Compare Similar Companies to PreCyte
Compare insights from companies similar to PreCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PreCyte is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PreCyte is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PreCyte.
PreCyte Tech Stack
A closer look at the technologies used by PreCyte
PreCyte News & Media
PreCyte and CIDR Announce $3M SBIR Phase IIB Funding for the Further...
PreCyte, Inc. a developer of innovative diagnostic tests for neurodegenerative and cancer, and the Center for Infectious Disease Research (CIDR) announced today that the National Institute on Aging... (PRWeb September 12, 2018) Read the full story at https://www.prweb.com/releases/precyte_and_cidr_announce_3m_sbir_phase_iib_funding_for_the_further_development_of_the_indicator_cell_assay_platform_icap_for_early_detection_of_alzheimer_s_disease/prweb15755195.htmPreCyte and CIDR Announce $2M SBIR Phase II Funding for the...
PreCyte, Inc. a developer of innovative diagnostic tests for neurodegenerative and other diseases, and the Center for Infectious Disease Research (CIDR) announced today that the National Cancer... (PRWeb September 12, 2018) Read the full story at https://www.prweb.com/releases/precyte_and_cidr_announce_2m_sbir_phase_ii_funding_for_the_application_of_the_indicator_cell_assay_platform_icap_for_the_early_detection_of_lung_cancer/prweb15755187.htm
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding PreCyte
Sign Up For FreeTo access detailed company insights
PreCyte offers the Indicator Cell Assay Platform (iCAP), an innovative and cost-effective blood-based assay designed for early disease detection and as a companion diagnostic in drug development. The iCAP utilizes standardized cultured cells as biosensors to enhance the detection of signals in blood or other fluids from both healthy and diseased in... Read More
